MedPath

The Harvard Drug Group, L.l.c.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

298

FDA:298

Drug Approvals

Fluphenazine Hydrochloride

Approval Date
Sep 11, 2025
FDA

Hydroxyurea

Approval Date
Sep 11, 2025
FDA

Guanfacine

Approval Date
Sep 11, 2025
FDA

Levetiracetam

Approval Date
Sep 11, 2025
FDA

Folic Acid

Approval Date
Sep 11, 2025
FDA

Aspirin

Approval Date
Aug 12, 2025
FDA

ciprofloxacin

Approval Date
Aug 6, 2025
FDA

Metoprolol succinate

Approval Date
Aug 6, 2025
FDA

Mycophenolate mofetil

Approval Date
Jun 19, 2025
FDA

Trazodone Hydrochloride

Approval Date
Jun 18, 2025
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 30
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.